US LNG exports surge but will buyers in China turn up?
CHICAGO - GE HealthCare (NASDAQ:GEHC), a prominent healthcare equipment provider with a market capitalization of $37.34 billion, has unveiled its latest computed tomography (CT) system, Revolution Vibe, at the American College of Cardiology 2025 meeting, aiming to advance cardiac imaging technology and improve patient care. The system features Unlimited One-Beat Cardiac imaging, designed to produce high-quality images for complex cardiac cases, and integrates artificial intelligence (AI) solutions to streamline diagnostic processes. According to InvestingPro analysis, GE HealthCare currently appears undervalued, with strong fundamentals including a healthy 41.71% gross profit margin.
Cardiovascular disease (CVD) remains the leading cause of death globally, with cardiac CT procedures expected to rise significantly. Revolution Vibe’s introduction is a response to the growing demand for advanced diagnostic tools like cardiac CT angiography (CCTA), which is recommended as the first-line investigation for suspected coronary artery disease (CAD). With annual revenue of $19.67 billion and EBITDA of $3.61 billion, GE HealthCare demonstrates the financial strength to continue investing in innovative solutions. InvestingPro identifies the company as trading at an attractive P/E ratio relative to its near-term earnings growth, with multiple additional ProTips available to subscribers.
The system is engineered to tackle the most challenging cardiac exams, addressing issues such as irregular heart rhythms and heavily calcified coronaries that often result in repeat scans and increased healthcare costs. Revolution Vibe’s technology is intended to make CCTA more accessible, improving diagnostic confidence and patient comfort while enhancing workflow efficiency.
Dr. Christopher Ahlers, a radiologist and managing partner at Radiomed, noted that the Revolution Vibe has doubled their CCTA capacity and reduced scan times, while also improving image quality. The system’s AI-powered solutions, such as ECG-less Cardiac and Effortless Cardiac Workflow, aim to simplify patient preparation and reduce exam times, ultimately benefiting both patients and healthcare providers.
In addition to its clinical benefits, Revolution Vibe is designed to help healthcare facilities expand their service lines and manage lifecycle costs effectively. Its energy-efficient design and Smart Subscription service ensure facilities remain up-to-date with the latest technology, supporting long-term investment decisions.
The system has received the CE mark and is pending 510(k) clearance with the U.S. FDA. It is not yet available for sale in the United States or all regions. The formal unveiling took place at GE HealthCare’s booth on Saturday, March 29.
GE HealthCare, a leading provider of medical technology and services, continues to innovate in the healthcare industry with the aim of improving efficiency, precision, and patient outcomes. The information in this article is based on a press release statement.
In other recent news, GE HealthCare reported fourth-quarter sales that aligned with consensus estimates, reaching $5.32 billion, a 2% increase year-over-year. Excluding China, the growth rate stood at 4%, while earnings per share (EPS) surpassed expectations at $1.45, up from the anticipated $1.26. The company’s orders increased by 6% year-over-year, with a book-to-bill ratio of 1.09, marking its strongest performance since going public. Jefferies analyst Matthew Taylor raised the stock’s price target to $110 from $103 and maintained a Buy rating, citing confidence in margin improvements and potential for exceeding fiscal year 2025 guidance. Additionally, GE HealthCare announced a collaboration with NVIDIA to advance AI imaging, focusing on automating X-ray and ultrasound technologies to ease the workload on healthcare professionals. The company also introduced its Genesis portfolio, a suite of cloud-based imaging solutions designed to enhance healthcare efficiency and precision. GE HealthCare declared a first-quarter dividend of $0.035 per share, payable on May 15, 2025, to shareholders of record as of April 25, 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.